A Texas man has filed a lawsuit against the makers of the antipsychotic drug Risperdal claiming he suffered long-term emotional problems after the drug caused him to grow female breasts.
Jacoby Moore filed his Risperdal lawsuit in Jefferon County District Court against Ortho-McNeil-Janssen Pharmaceuticals Inc., formerly known as Janssen Pharmaceuticals Inc., Johnson & Johnson Company, Johnson & Johnson Research and Development, and Dr. Ravikumar Kanneganti both individually and doing business as Child Guidance Center.
Moore says he was prescribed Risperdal by Kanneganti when he was 7 to treat attention deficit disorder (ADHD). Risperdal, known generically as risperidone, is approved to treat schizophrenia, bipolar disorder and irritability with autism in adults. It is often prescribed off-label to treat ADHD and other behavioral problems. In 2006, the indication was expanded to include pediatric patients with schizophrenia, bipolar and autism.
Doctors are free to prescribe drugs for conditions for which they are not approved, however drug companies cannot promote drugs for unapproved uses. Last year, Janssen paid $2.2 billion to settle criminal and other charges involving illegal promotion of Risperdal.
Moore’s Risperdal lawsuit claims that the drug companies were aware that Risperdal caused adolescent boys to grow breasts, a condition known as gynecomastia, but the company refused to warn doctors or patients of this risk and even tried to manipulate data that showed Risperdal side effects in boys and young men.
Gynecomastia can be painful, leaving both emotional scars and causing physical symptoms such as breast tenderness and lactation. Treatment generally involves surgery to remove breast tissue with either liposuction or mastectomy.
Source: Southeast Texas Record